Manchester Royal Infirmary, Biomedical Research Centre, University of Manchester, Manchester, UK.
Nephrol Dial Transplant. 2013 Oct;28(10):2612-20. doi: 10.1093/ndt/gft294.
Resurgence of interest in home haemodialysis (HHD) is, in part, due to emerging evidence of the benefits of extended HD regimens, which are most feasibly provided in the home setting. Although specific HHD therapy established at home such as nocturnal HD (NHD) has been reported from individual programmes, little is known about overall HHD success.
The study included 166 patients who were accepted in the Manchester (UK) HHD training programme through liberal selection criteria. All patients were followed up prospectively until a switch to alternative modality, to include 4528 patient-months of follow-up and about 81 508 HHD sessions during an 8-year period (January 2004-December 2011). Twenty-four patients switched to an alternative modality during the period. Combined technique survival (HHDc) as a composite of training (HHDtr) and at home (HHDhome) was analysed and clinical predictors of HHD modality failure since the commencement of the programme were calculated using Cox regression analysis. Technology-related interruptions to dialysis over a 12-month period and patient-reported reasons for quitting the programme were analysed.
Technique survival at 1, 2 and 5 years was 90.2, 87.4, 81.5% (HHDc) and 98.4, 95.4 and 88.9% (HHDhome) when censored for training phase exits, death and transplantation. The combined HHDc modality switch rate is 1 in 192 patient-months of dialysis follow-up. Age >60 years, diabetes, cardiac failure, unit decrease in Hb and increasing score of age-adjusted Charlson--comorbidity index were significantly associated with technique failure. Significant clinical predictors of HHD technique failure in a multivariate model were diabetes (P = 0.002) and cardiac failure (P = 0.05). The majority (61%) switched to an alternative modality for non-medical reasons. The composite of operator error and mechanical breakdown resulting in temporary HHD technique failure was 0.7% per year.
HHD training and technique failure rate are low. Technical errors are infrequent too. Diabetes and cardiac failure are associated with significant risk of technique failure. Although absolute rates are low, training failure is proportionally quite significant, highlighting the importance of reporting the composite technique failure rate (to include early HHD training phase) in HHD programmes.
家庭血液透析(HHD)的兴趣再度兴起,部分原因是扩展血液透析方案的益处逐渐得到证实,而这些方案最有可能在家庭环境中提供。尽管已经从个别项目中报告了在家中进行的特定 HHD 治疗,例如夜间血液透析(NHD),但对于整体 HHD 的成功情况知之甚少。
该研究纳入了 166 名患者,他们通过宽松的选择标准被纳入曼彻斯特(英国)HHD 培训计划。所有患者均前瞻性随访,直至转为替代治疗模式,8 年期间(2004 年 1 月至 2011 年 12 月)共随访 4528 患者月,约 81508 次 HHD 治疗。在此期间,有 24 名患者转为替代治疗模式。采用 Cox 回归分析计算培训(HHDtr)和家庭(HHDhome)相结合的技术存活率(HHDc),以及该方案开始以来 HHD 治疗模式失败的临床预测因素。分析了 12 个月内与技术相关的透析中断以及患者退出该计划的原因。
当训练阶段退出、死亡和移植进行删失时,HHDc 技术存活率为 1 年时为 90.2%,2 年时为 87.4%,5 年时为 81.5%,HHDhome 为 1 年时为 98.4%,2 年时为 95.4%,5 年时为 88.9%。结合 HHDc 模式转换率为每 192 个患者月透析随访 1 次。年龄>60 岁、糖尿病、心力衰竭、Hb 单位下降以及年龄调整 Charlson 合并症指数评分增加与技术失败显著相关。多变量模型中,HHD 技术失败的显著临床预测因素为糖尿病(P=0.002)和心力衰竭(P=0.05)。大多数(61%)患者因非医疗原因转为替代治疗模式。操作员错误和机械故障导致的临时 HHD 技术失败的复合发生率为每年 0.7%。
HHD 培训和技术失败率较低。技术错误也很少见。糖尿病和心力衰竭与技术失败的显著风险相关。尽管绝对比率较低,但培训失败的比例相当高,这凸显了在 HHD 计划中报告复合技术失败率(包括早期 HHD 培训阶段)的重要性。